These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 28862224)
1. Honey bee venom combined with 1,25-dihydroxyvitamin D Mohseni-Kouchesfahani H; Nabioni M; Khosravi Z; Rahimi M J Cancer Res Ther; 2017; 13(3):544-549. PubMed ID: 28862224 [TBL] [Abstract][Full Text] [Related]
2. Ethacrynic acid and 1 alpha,25-dihydroxyvitamin D3 cooperatively inhibit proliferation and induce differentiation of human myeloid leukemia cells. Makishima M; Honma Y Leuk Res; 1996 Sep; 20(9):781-9. PubMed ID: 8947589 [TBL] [Abstract][Full Text] [Related]
3. l-Asparaginase-mediated downregulation of c-Myc promotes 1,25(OH) Song JH; Park E; Kim MS; Cho KM; Park SH; Lee A; Song J; Kim HJ; Koh JT; Kim TS Int J Cancer; 2017 May; 140(10):2364-2374. PubMed ID: 28224619 [TBL] [Abstract][Full Text] [Related]
4. 1,25-Dihydroxyvitamin D3-induced differentiation in a human promyelocytic leukemia cell line (HL-60): receptor-mediated maturation to macrophage-like cells. Mangelsdorf DJ; Koeffler HP; Donaldson CA; Pike JW; Haussler MR J Cell Biol; 1984 Feb; 98(2):391-8. PubMed ID: 6319426 [TBL] [Abstract][Full Text] [Related]
5. A novel uracil analog, 6-chloro-5-(2-propenyl)uracil, preferentially enhances growth inhibition and differentiation of myeloid leukemia cells induced by 1alpha,25-dihydroxyvitamin D3. Kanatani Y; Makishima M; Ishikawa I; Ogasawara Y; Kawahara N; Motoyoshi K; Nagata N; Honma Y Exp Hematol; 1998 Mar; 26(3):198-206. PubMed ID: 9502615 [TBL] [Abstract][Full Text] [Related]
6. Alternative differentiation of human promyelocytic leukemia cells (HL-60) induced selectively by retinoic acid and 1 alpha,25-dihydroxyvitamin D3. Miyaura C; Abe E; Suda T; Kuroki T Cancer Res; 1985 Sep; 45(9):4244-8. PubMed ID: 2992776 [TBL] [Abstract][Full Text] [Related]
7. Novel analogs of 1,25-dihydroxyvitamin D Nachliely M; Sharony E; Kutner A; Danilenko M J Steroid Biochem Mol Biol; 2016 Nov; 164():59-65. PubMed ID: 26365556 [TBL] [Abstract][Full Text] [Related]
8. Synergistic effects of clinically achievable concentrations of 12-O-tetradecanoylphorbol-13-acetate in combination with all-trans retinoic acid, 1alpha,25-dihydroxyvitamin D3, and sodium butyrate on differentiation in HL-60 cells. Zheng X; Chang RL; Cui XX; Kelly KA; Shih WJ; Lin Y; Strair R; Suh J; Han ZT; Rabson A; Conney AH Oncol Res; 2000; 12(9-10):419-27. PubMed ID: 11697820 [TBL] [Abstract][Full Text] [Related]
9. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells. Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928 [TBL] [Abstract][Full Text] [Related]
10. Factors responsible for variable reported lineages of HL-60 cells induced to mature with butyric acid. Hoessly MC; Rossi RM; Fischkoff SA Cancer Res; 1989 Jul; 49(13):3594-7. PubMed ID: 2567205 [TBL] [Abstract][Full Text] [Related]
11. Effects of 1 alpha, 25-dihydroxyvitamin D3 on the human chronic myelogenous leukemia cell line RWLeu-4. Lasky SR; Bell W; Huhn RD; Posner MR; Wiemann M; Calabresi P; Eil C Cancer Res; 1990 May; 50(10):3087-94. PubMed ID: 2159372 [TBL] [Abstract][Full Text] [Related]
12. An in vitro Experimental Insight into the Osteoblast Responses to Vitamin D3 and Its Metabolites. Wang D; Song J; Ma H Pharmacology; 2018; 101(5-6):225-235. PubMed ID: 29393236 [TBL] [Abstract][Full Text] [Related]
13. Modulation of CD157 expression in multi-lineage myeloid differentiation of promyelocytic cell lines. Hussain AM; Lee HC; Chang CF Eur J Cell Biol; 2000 Oct; 79(10):697-706. PubMed ID: 11089918 [TBL] [Abstract][Full Text] [Related]
14. Targeting peroxiredoxin I potentiates 1,25-dihydroxyvitamin D3-induced cell differentiation in leukemia cells. Wei W; Liu C; Qin D; Song L; Xia L; Lei H; Yu Y; Wang W; Pu J; Sun H; Wu Y; Xu H; Hao S Mol Med Rep; 2016 Mar; 13(3):2201-7. PubMed ID: 26783013 [TBL] [Abstract][Full Text] [Related]
15. Angelmicin B, a new inhibitor of oncogenic signal transduction, inhibits growth and induces myelomonocytic differentiation of human myeloid leukemia HL-60 cells. Yokoyama A; Okabe-Kado J; Uehara Y; Oki T; Tomoyasu S; Tsuruoka N; Honma Y Leuk Res; 1996 Jun; 20(6):491-7. PubMed ID: 8709621 [TBL] [Abstract][Full Text] [Related]
16. [Enhancement of differentiation induction of HL-60 cells by 1,25-dihydroxyvitamin D3 in combination with carnosic acid]. Ren LH; Chen JJ; An HP Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):55-9. PubMed ID: 18289473 [TBL] [Abstract][Full Text] [Related]
17. Effects of transforming growth factor-beta and activin A on vitamin D3-induced monocytic differentiation of myeloid leukemia cells. Okabe-Kado J; Honma Y; Hayashi M; Hozumi M Anticancer Res; 1991; 11(1):181-6. PubMed ID: 2018352 [TBL] [Abstract][Full Text] [Related]
18. Induced differentiation of human myeloid leukemia cells into M2 macrophages by combined treatment with retinoic acid and 1α,25-dihydroxyvitamin D3. Takahashi H; Hatta Y; Iriyama N; Hasegawa Y; Uchida H; Nakagawa M; Makishima M; Takeuchi J; Takei M PLoS One; 2014; 9(11):e113722. PubMed ID: 25409436 [TBL] [Abstract][Full Text] [Related]
19. Antioxidants and doxorubicin supplementation to modulate CD14 expression and oxidative stress induced by vitamin D3 and seocalcitol in HL60 cells. Bondza-Kibangou P; Millot C; El Khoury V; Millot JM Oncol Rep; 2007 Dec; 18(6):1513-9. PubMed ID: 17982638 [TBL] [Abstract][Full Text] [Related]
20. Etoposide stimulates 1,25-dihydroxyvitamin D3 differentiation activity, hormone binding and hormone receptor expression in HL-60 human promyelocytic cells. Torres R; Calle C; Aller P; Mata F Mol Cell Biochem; 2000 May; 208(1-2):157-62. PubMed ID: 10939640 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]